AMICUS THERAPEUTICS, INC. — Director's Dealing 2010

Mar 3, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2010-03-02

Reporting Person: Crowley John F (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-02	Common Stock	P	11898	$3.69	Acquired	71634	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-02	Warrants	$4.43	P	11898	Acquired	2014-03-02	Common Stock (4461)	Direct

Footnotes

F1: The warrants have a term of four years and are exercisable any time on or after the six month anniversary of the date they are issued, which is March 2, 2010.